Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial

Olivier Caron, Thierry Frebourg, Patrick R Benusiglio, Stéphanie Foulon, Laurence Brugières, Olivier Caron, Thierry Frebourg, Patrick R Benusiglio, Stéphanie Foulon, Laurence Brugières

Abstract

This interim analysis of an ongoing randomized clinical trial presents preliminary findings regarding use of whole-body magnetic resonance imaging for cancer surveillance of TP53 mutation carriers.

Trial registration: ClinicalTrials.gov NCT01464086.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Source: PubMed

3
订阅